Literature DB >> 7575570

Structural analysis of invasion plasmid antigen D (IpaD) from Shigella flexneri.

M E Marquart1, W L Picking, W D Picking.   

Abstract

Invaison plasmid antigen D (IpaD) and water-extracted outer-membrane proteins (OMPs) from Shigella flexneri were used to investigate some of the structural relationships of this pathogen's invasions. Extracellular presentation of the three invasion plasmid antigens (Ipa) B, C, and D is required for the S. flexneri invasive phenotype; however, little is known of the structural properties of these essential virulence components. Biochemical data suggest IpaB, C, and D present in S. flexneri OMPs from soluble protein complexes and IpaD may be able to form large homopolymeric complexes.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7575570     DOI： 10.1006/bbrc.1995.2380

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  12 in total

1.  Soluble invasion plasmid antigen C (IpaC) from Shigella flexneri elicits epithelial cell responses related to pathogen invasion.

Authors:  M E Marquart; W L Picking; W D Picking
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

Authors:  K R Turbyfill; J A Mertz; C P Mallett; E V Oaks
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Authors:  Wendy L Picking; Hiroaki Nishioka; Patricia D Hearn; M Aaron Baxter; Amanda T Harrington; Ariel Blocker; William D Picking
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.

Authors:  K L Kotloff; F R Noriega; T Samandari; M B Sztein; G A Losonsky; J P Nataro; W D Picking; E M Barry; M M Levine
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems.

Authors:  Marianela Espina; S Fernando Ausar; C Russell Middaugh; M Aaron Baxter; William D Picking; Wendy L Picking
Journal:  Protein Sci       Date:  2007-02-27       Impact factor: 6.725

6.  Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella flexneri.

Authors:  Chelsea R Epler; Nicholas E Dickenson; Esther Bullitt; Wendy L Picking
Journal:  J Mol Biol       Date:  2012-04-02       Impact factor: 5.469

7.  IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri.

Authors:  Marianela Espina; Andrew J Olive; Roma Kenjale; David S Moore; S Fernando Ausar; Robert W Kaminski; Edwin V Oaks; C Russell Middaugh; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip.

Authors:  Kenneth F Stensrud; Philip R Adam; Cassandra D La Mar; Andrew J Olive; Gerald H Lushington; Raghavi Sudharsan; Naomi L Shelton; Richard S Givens; Wendy L Picking; William D Picking
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

9.  Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein.

Authors:  Aaron P Markham; Zane A Jaafar; Kyle E Kemege; C Russell Middaugh; P Scott Hefty
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

10.  Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Authors:  Francisco J Martinez-Becerra; Xiaotong Chen; Nicholas E Dickenson; Shyamal P Choudhari; Kelly Harrison; John D Clements; William D Picking; Lillian L Van De Verg; Richard I Walker; Wendy L Picking
Journal:  Infect Immun       Date:  2013-09-23       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.